Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.

@article{Salem2004UsefulnessAS,
  title={Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.},
  author={Mohammed Ali Salem and Svein Rotevatn and Sindre Stavnes and Magne Brekke and Stein Emil Vollset and Jan Erik Nordrehaug},
  journal={The American journal of cardiology},
  year={2004},
  volume={93 9},
  pages={1086-91}
}
This prospective, double-blind, randomized, sham-controlled trial was designed to control for patient and investigator bias in assessing symptomatic improvement after percutaneous myocardial laser revascularization (PMLR) therapy. Eighty-two patients with stable angina pectoris (class III or IV) not amenable to conventional revascularization and with evidence of reversible ischemia, ejection fraction >/=25%, and myocardial wall thickness >/=8 mm were randomized to either PMLR with optimal… CONTINUE READING